Matthew J Inkman

11PUBLICATIONS
106CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Food engineeringPredictive and prognostic markersTumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 20, 2026
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer.

Tito A Sandoval, Yize Li, Naoshad Muhammad

|Dec 05, 2024
Dietary fructose enhances tumour growth indirectly via interorgan lipid transfer.

Ronald Fowle-Grider, Joe L Rowles, Isabel Shen

|Nov 08, 2023
Sensitive MRD Detection from Lymphatic Fluid after Surgery in HPV-Associated Oropharyngeal Cancer.

Noah Earland, Nicholas P Semenkovich, Ricardo J Ramirez

|Jul 03, 2023
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival.

Emilee N Kotnik, Mary M Mullen, Nicholas C Spies

|Apr 24, 2023
Intrinsic tumor resistance to CAR T cells is a dynamic transcriptional state that is exploitable with low-dose radiation.

Alexander B Kim, Ssu-Yu Chou, Solomon Kang

|Mar 08, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy.

Douglas V Faget, Xianmin Luo, Matthew J Inkman

Pageof 2

Frequent Collaborators

10 joint publications

Jin Zhang

3 joint publications

Kay Jayachandran

3 joint publications

Julie K Schwarz

3 joint publications

David G DeNardo